Please assess the completion status of the following clinical trial:

Trial Title: Triple Therapy for Postoperative Nausea and Vomiting in Laparoscopic Gastrointestinal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18 years and Age ≤75 years;~* Scheduled for laparoscopic gastrointestinal surgical procedure with general anesthesia ;~* The score evaluated by Apfel simplified PONV risk assessment systems is ≥3.~Exclusion Criteria:~* The American Society of Anesthesiologists (ASA) rating is \>3;~* Severe hepatic dysfunction(the score of Child-Pugh is \>9);~* With contraindications for using fosaprepitant, 5-HT3 receptor antagonist or dexamethasone ;~* Take medications with known antiemetic properties preoperatively ;~* With mental disorder, or not be able to communicate ;~* Pregnant women or nursing mothers.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- triple therapy (Type: EXPERIMENTAL): Triple combination of Fosaprepitant, Palonosetron and Dexamethasone were administered
- double therapy (Type: OTHER): double combination of Palonosetron and Dexamethasone were administered

Based on this trial design, predict the completion outcome and termination type (if applicable).